I
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Recent Filings
- SC 13G/A8.5 KBINTROGEN THERAPEUTICS INCFeb 17, 3:13 PM ET·0000315066-09-001821
- SC 13G/A8.6 KBINTROGEN THERAPEUTICS INCFeb 13, 5:32 PM ET·0001422848-09-000278
- 8-K15.0 KBINTROGEN THERAPEUTICS INCJan 13, 5:20 PM ET·0000950134-09-000477
- 8-K29.5 KBINTROGEN THERAPEUTICS INCJul 22, 7:26 PM ET·0001157523-08-005732
- 8-K27.7 KBINTROGEN THERAPEUTICS INCJul 3, 6:06 PM ET·0001157523-08-005364
- 45.6 KBINTROGEN THERAPEUTICS INCMay 20, 3:37 PM ET·0001426170-08-000008
- 45.7 KBINTROGEN THERAPEUTICS INCMay 20, 3:28 PM ET·0001426170-08-000007
- 45.6 KBINTROGEN THERAPEUTICS INCMay 20, 3:02 PM ET·0001426170-08-000006
- 45.7 KBINTROGEN THERAPEUTICS INCMay 20, 2:53 PM ET·0001426170-08-000005
- 45.6 KBINTROGEN THERAPEUTICS INCMay 20, 2:42 PM ET·0001426170-08-000004
Insiders
10- ALBRECHT JAMES W JRChief Executive Officer
- AVENTIS HOLDINGS INC10% owner and beneficial owner
- AVENTIS INC10% owner and beneficial owner
- CUNNINGHAM WILLIAM H DRDirector
- ENLOE J DAVID JRSr. Vice President
- FINNEGAN G THOMAS IIIVice President
- GALLAGHER SHAWN Lvice president
- GILLIS STEPHEN MALCOLMDirector
- HUTT PETER BARTONDirector
- KAPOOR JOHN NDirector, 10% Owner
Tickers
No tickers on record
Addresses
business
301 CONGRESS AVE SUITE 1850
AUSTIN, TX, 78701
mailing
301 CONGRESS AVE SUITE 1850
AUSTIN, TX, 78701